COMP <GO>
HQY vs AMZN // 10Y YIELD & FRED MACRO BETA
HealthEquity Inc. (NASDAQ) VS. Amazon.com, Inc. (NASDAQ) • 15-METRIC TALLY: HQY 4
— AMZN 6
▲ 10Y YIELD & FRED MACRO BETA LEADER: AMZN
LAST: $102.47 (+1.10%) • MKT CAP: $8.38B
macro-sensitivity
0.96
LAST: $240.35 (-1.41%) • MKT CAP: $2.59T
macro-sensitivity
1.46
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HQY VS. AMZN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HQY | AMZN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 69.50% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.30% | 17.61% | -8.31 | AMZN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 27.8x | 15.8x | +12.05 | AMZN | /valuation <GO> |
| Free Cash Flow Yield | 5.43% | -1.81% | +7.24 | HQY | /fcf-yield <GO> |
| Operating Margin | 24.60% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 16.40% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 9.50% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.86 | 3.32 | +1.54 | HQY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 6/9 | +3.00 | HQY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 6.73% | +0.07 | AMZN | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 66.3 | 38.3 | +28.07 | HQY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.96 | 1.46 | -0.50 | AMZN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 36.3x | 22.8x | +13.55 | AMZN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $8.38B | $2.59T | -$2.58T | AMZN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HQY REV | AMZN REV | HQY GROSS % | AMZN GROSS % | HQY FCF | AMZN FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $0 | — | — | — | -$46.89B |
| FY 2025 | $1.31B | $0 | 69.5% | — | $455.1M | $10.56B |
| FY 2024 | $1.20B | $0 | 64.8% | — | $337.8M | $42.95B |
| FY 2023 | $999.6M | $0 | 44.0% | — | $197.8M | $16.92B |
| FY 2022 | — | $0 | — | — | — | -$26.32B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HQY // BETA 0.96
AMZN // BETA 1.46